A specific phospholipase C activity regulates phosphatidylinositol levels in lung surfactant of patients with acute respiratory distress syndrome

American Journal of Respiratory Cell and Molecular Biology

Volumn 42, Issue 3, 2010, Pages 357-362

  Spyridakis, Spyros ^a   Leondaritis, George ^a,d   Nakos, George ^b   Lekka, Marilena E ^c   Galanopoulou, Dia ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^c UNIVERSITY OF IOANNINA   (Greece)

^d UNIVERSITY OF THESSALY   (Greece)

Author keywords

Acute respiratory distress syndrome; Lung surfactant; Phosphatidylinositol; Phosphatidylinositol 4,5 bisphosphate; Phospholipase C

Indexed keywords

CALCIUM; LUNG SURFACTANT; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PHOSPHOLIPASE C;

ADOLESCENT; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SPECIFICITY; ENZYME SUBSTRATE; FEMALE; FRACTIONATION; HUMAN; LUNG INJURY; LUNG LAVAGE; MALE; MAMMAL; PH; SCHOOL CHILD;

ADULT; AGED; BRONCHOALVEOLAR LAVAGE FLUID; CALCIUM; DEMOGRAPHY; EXTRACELLULAR SPACE; FEMALE; HUMANS; HYDROLYSIS; INTRACELLULAR SPACE; MALE; MIDDLE AGED; PHOSPHATIDYLINOSITOL PHOSPHATES; PHOSPHOINOSITIDE PHOSPHOLIPASE C; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, ADULT; SUBSTRATE SPECIFICITY;

MAMMALIA;

EID: 77249112320     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2009-0078OC     Document Type: Article

References (45)

1. Nakos G, Kitsiouli EI, Lekka ME. Bronchoalveolar lavage alterations in pulmonary embolism. Am J Respir Crit Care Med 1998;158:1504-1510.
2. Van Golde LMG, Batenburg JJ, Robertson B. The pulmonary surfactant system: biochemical aspects and functional significance. Physiol Rev 1988;68:374-455.
3. Crouch E, Wright JR. Surfactant proteins A and D and pulmonary host defense. Annu Rev Physiol 2001;63:521-554.
4. Veldhuizen R, Nag K, Orgeig S, Possmayer F. The role of lipids in pulmonary surfactant. Biochim Biophys Acta 1998;1408:90-108.
5. Ingenito EP, Mora R, Mark L. Pivotal role of anionic phospholipids in determining dynamic behavior of lung surfactant. Am J Respir Crit Care Med 2000;161:831-838.
6. Kulovich MV, Hallman MB, Gluck L. The lung profile: I. Normal pregnancy. Am J Obstet Gynecol 1979;135:57-63.
7. Ogasawara Y, Kuroki Y, Akino T. Pulmonary surfactant protein D specifically binds to phosphatidylinositol. J Biol Chem 1992;267:21244-21249.
8. 2 and platelet-activating-factor acetylhydrolase in patients with acute respiratory distress syndrome. Crit Care Med 2005;33:772-779.
9. 2 in mice leads to neonatal lethality because of lung dysfunction. J Biol Chem 2006;281:36420-36433.
10. Berger A, Havet N, Vial D, Arbibe I, Dumarey C, Watson ML, Touqui L. Dioleylphosphatidylglycerol inhibits the expression of type II phospholipase A2 in macrophages. Am J Respir Crit Care Med 1999;159:613-618.
11. Kishikawa T. Phospholipase activities of surfactant fractions and their role in the morphological change in surfactants in vitro. J Submicrosc Cytol Pathol 1990;22:507-513.
12. Rebecchi MJ, Pentyala SN. Structure, function, and control of phosphoinositide-specific phospholipase C. Physiol Rev 2000;80:1291-1335.
13. Rhee SG. Regulation of phosphoinositide-specific phospholipase C. Annu Rev Biochem 2001;70:281-312.
14. Suh P-G, Park J-I, Manzoli L, Cocco L, Peak JC, Katan M, Fukami K, Kataoka T, Yun S, Ryu SH. Mutliple roles of phosphoinositidespecific phospholipase C isozymes. BMB Rep 2008;41:415-434.
15. Birrell GB, Hedberg KK, Griffith OH. An extracellular inositol phospholipid-specific phospholipase C is released by cultured Swiss 3T3 cells. Biochem Biophys Res Commun 1995;211:318-324.
16. Berridge MJ, Lipp P, Bootman MD. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 2000;1:11-21.
17. Michell RH. The multiplying roles of inositol lipids and phosphates in cell control processes. Essays Biochem 1997;32:31-47.
18. Gobran LI, Xu Z-X, Rooney SA. PKC isoforms and other signaling proteins involved in surfactant secretion in developing rat type II cells. Am J Physiol 1998;274:L901-L908.
19. Ramadurai AM, Chen W-Y, Yerozolimsky GB, Zagami M, Dammann CEL, Nielsen HC. Cell-specific and developmental expression of phospholipase C-γ and diacylglycerol in fetal lung. Am J Physiol 2003; 284:L808-L816.
20. Hwang J-I, Oh Y-S, Shin K-J, Kim H, Ryu SH, Suh P-G. Molecular cloning and characterization of a novel phospholipase C, PLCh. Biochem J 2005;389:181-186.
21. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818-824.
22. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin Phenol reagent. J Biol Chem 1951;193:265-275.
23. Schacht J. Extraction and purification of polyphosphoinositides. Methods Enzymol 1981;72:626-631.
24. Marinetti GV. Chromatographic separation, identification and analysis of phosphatides. J Lipid Res 1962;3:1-20.
25. Leondaritis G, Galanopoulou D. Characterization of inositol phospholipids and identification of a mastoparan-induced polyphosphoinositide response in Tetrahymena pyriformis. Lipids 2000;35:525-532.
26. Melin PM, Sundler R, Jergil B. Phospholipase C in rat liver plasma membranes: phosphoinositide specificity and regulation by guanine nucleotides and calcium. FEBS Lett 1986;198:85-88.
27. Homma Y, Emori Y. Purification and assay of PLCd. In: Shears SB, editor. Signaling by inositides. Oxford, UK: IRL Press; 1997. pp. 99-116.
28. James SR, Paterson A, Harden TK, Downes CP. Kinetic analysis of phospholipase C beta isoforms using phospholipid-detergent mixed micelles: evidence for interfacial catalysis involving distinct micelle binding and catalytic steps. J Biol Chem 1995;270:11872-11881.
29. Corda D, Iurisci C, Berrie CP. Biological activities and metabolism of the lysophosphoinositides and glycerophosphoinositols. Biochim Biophys Acta 2002;1582:52-69.
30. Veldhuizen RA, McCaig LA, Akino T, Lewis JF. Pulmonary surfactant subfractions in patients with the acute respiratory distress syndrome. Am J Respir Crit Care Med 1995;152:1867-1871.
31. Rhee SG, Suh PG, Ryu SH, Lee SY. Studies of inositol phospholipidspecific phospholipase C. Science 1989;244:546-550.
32. Litosch I. Guanine nucleotide and NaF stimulation of phospholipase C activity in rat cerebral-cortical membranes. Biochem J 1987;244:35-40.
33. Hendrickson HS, Dennis EA. Kinetic analysis of the dual phospholipid model for phospholipase A2 action. J Biol Chem 1984;259:5734-5739.
34. Volwerk JJ, Filthuth E, Griffith OH, Jain MK. Phosphatidylinositol- specific phospholipase C from Bacillus cereus at the lipid-water interface: interfacial binding, catalysis and activation. Biochemistry 1994;33:3464-3474.
35. Cifuentes ME, Honkanen L, Rebecchi MJ. Proteolytic fragments of phosphoinositide-specific phospholipase C-delta 1. Catalytic and membrane binding properties. J Biol Chem 1993;268:11586-11593.
36. Wahl MI, Jones GA, Nishibe S, Rhee SG, Carpenter G. Growth factor stimulation of phospholipase C-gamma 1 activity: comparative properties of control and activated enzymes. J Biol Chem 1992;267:10447-10456.
37. Nakos G, Kitsiouli EI, Tsangaris I, Lekka ME. Bronchoalveolar lavage fluid characteristics of early intermediate and late phases of ARDS: alterations in leukocytes, proteins, PAF and surfactant components. Intensive Care Med 1998;24:296-303.
38. Schmidt R,Meier U, Yabut-Perez M, Walmrath D, Grimminger F, Seeger W, Günther A. Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome and severe pneumonia. Am J Respir Crit Care Med 2001;163:95-100.
39. Ohmer-Schröck D, Schlatterer C, Plattner H, Schlepper-Schäfer J. Lung surfactant protein A (SP-A) activates a phosphoinositide/calcium signaling pathway in alveolar macrophages. J Cell Sci 1995;108:3695-3702.
40. Banan A, Zhang LJ, Shaikh M, Fields JZ, Farhadi A, Keshavarzian A. Key role of PLC-g in EGF protection of epithelial barrier against iNOS upregulation and F-actin nitration and disassembly. Am J Physiol Cell Physiol 2003;285:C977-C993.
41. Ikegami M, Grant S, Korfhagen TR, Scheule RK, Whitsett JA. Surfactant protein-D regulates the postnatal maturation of pulmonary surfactant lipid pool sizes. J Appl Physiol 2009;106:1545-1552.
42. Cochrane CG. Pulmonary surfactant in allergic inflammation: mew insights into the molecular mechanisms of surfactant function. Am J Physiol Lung Cell Mol Physiol 2005;288:L608-L609.
43. Veldhuizen R, Possmayer F. Phospholipid metabolism in lung surfactant. Subcell Biochem 2004;37:359-388.
44. Hite RD, Seeds MC, Bowton DL, Grier BL, Safta AM, Balkrishnan R, Waite BM, Bass DA. Surfactant phospholipids changes after antigen challenge: a role for phosphatidylglycerol in dysfunction. Am J Physiol Lung Cell Mol Physiol 2005;288:L610-L617.
45. Mander A, Langton-Hewer S, Bernhard W, Warner JO, Postle AD. Altered phospholipid composition and aggregate structure of lung surfactant is associated with impaired lung function in young children with respiratory infections. Am J Respir Cell Mol Biol 2002;27:714-721.